The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease

被引:164
|
作者
Cheng, Ying [1 ]
Bai, Feng [2 ]
机构
[1] Southeast Univ, Sch Med, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
来源
FRONTIERS IN NEUROSCIENCE | 2018年 / 12卷
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; tau; mitochondrial transport; mitochondrial dynamics; mitochondrial dysfunction; AXONAL-TRANSPORT DEFECTS; OXIDATIVE STRESS; PHOSPHORYLATED TAU; AMYLOID-BETA; NEURODEGENERATIVE DISEASES; HYPERPHOSPHORYLATED TAU; SYNAPTIC DYSFUNCTION; ABNORMAL INTERACTION; MOUSE MODEL; PROTEIN-TAU;
D O I
10.3389/fnins.2018.00163
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence suggests that abnormally hyperphosphorylated tau plays a vital role in the pathogenesis of Alzheimer's disease (AD). Mitochondrial dysfunction also has a recognized role in the pathophysiology of AD. In recent years, mitochondrial dysfunction has been strongly associated with tau pathology in AD. Overexpression of hyperphosphorylated and aggregated tau appears to damage the axonal transport, leading to abnormal mitochondrial distribution. In addition, pathological tau impairs mitochondrial dynamics by regulating mitochondrial fission/fusion proteins, and further causes mitochondrial dysfunction and neuronal damage. Moreover, mitochondrial dysfunction is also involved in promoting tau pathology in AD. In this article, we evaluate the relationship between phosphorylated tau and mitochondrial dysfunction in AD.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease
    Misrani, Afzal
    Tabassum, Sidra
    Yang, Li
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [32] Mitochondrial dysfunction and neuronal apoptosis in Alzheimer's disease
    Takuma, Kazuhiro
    Fukuzaki, Emiko
    Nagai, Taku
    Mizoguchi, Hiroyuki
    Stern, David M.
    Yan, Shirley ShiDu
    Yamada, Kiyofumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 45P - 45P
  • [33] Mitochondrial dysfunction and mitophagy failure in Alzheimer's disease
    Mary, Arnaud
    Vaillant-Beuchot, Loan
    Checler, Frederic
    Chami, Mounia
    M S-MEDECINE SCIENCES, 2021, 37 (10): : 843 - 847
  • [34] Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer's Disease
    Onukwufor, John O.
    Dirksen, Robert T.
    Wojtovich, Andrew P.
    ANTIOXIDANTS, 2022, 11 (04)
  • [35] Mitochondrial Dysfunction in Alzheimer's Disease: A Biomarker of the Future?
    Bell, Simon M.
    Barnes, Katy
    De Marco, Matteo
    Shaw, Pamela J.
    Ferraiuolo, Laura
    Blackburn, Daniel J.
    Venneri, Annalena
    Mortiboys, Heather
    BIOMEDICINES, 2021, 9 (01) : 1 - 26
  • [36] Mitochondrial dysfunction and cellularmetabolic deficiency in Alzheimer's disease
    Xue-Mei Gu 1
    Neuroscience Bulletin, 2012, 28 (05) : 631 - 640
  • [37] Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease
    Cai, Qian
    Tammineni, Prasad
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (04) : 1087 - 1103
  • [38] Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
    Moreira, Paula I.
    Carvalho, Cristina
    Zhu, Xiongwei
    Smith, Mark A.
    Perry, George
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (01): : 2 - 10
  • [39] Mitochondrial Dysfunction: Cause and Consequence of Alzheimer's Disease
    Friedland-Leuner, Kristina
    Stockburgert, Carola
    Denzer, Isabel
    Eckert, Gunter P.
    Mueller, Walter E.
    MITOCHONDRION IN AGING AND DISEASE, 2014, 127 : 183 - 210
  • [40] Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease
    Gunter P. Eckert
    Kathrin Renner
    Schamim H. Eckert
    Janett Eckmann
    Stephanie Hagl
    Reham M. Abdel-Kader
    Christopher Kurz
    Kristina Leuner
    Walter E. Muller
    Molecular Neurobiology, 2012, 46 : 136 - 150